ELABS.OL

Elliptic Laboratories ASA [ELABS.OL] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ELABS.OL Stock Summary

Top 10 Correlated Stocks

ELABS.OL


In the News

ELABS.OL Financial details

Company Rating
Sell
Market Cap
1.5B
Income
-38M
Revenue
68.32M
Book val./share
2.91
Cash/share
1.09
Dividend
-
Dividend %
-
Employees
72
Optionable
No
Shortable
Yes
Earnings
23 May 2024
P/E
-44.65
Forward P/E
-
PEG
-37.7
P/S
25.33
P/B
5.1
P/C
12.83
P/FCF
-22.31
Quick Ratio
6.1
Current Ratio
10.65
Debt / Equity
0.03
LT Debt / Equity
0.01
-
-
EPS (TTM)
-0.36
EPS next Y
-
EPS next Q
-
EPS this Y
12.5%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
22.59%
Revenue last 5Y
12.47%
Revenue Q/Q
-57.87%
EPS Q/Q
186.58%
-
-
-
-
SMA20
-3.62%
SMA50
-14.33%
SMA100
-18.16%
Inst Own
-
Inst Trans
-
ROA
-10%
ROE
-11%
ROC
-0.12%
Gross Margin
-10%
Oper. Margin
-62%
Profit Margin
-54%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
10.22-19.86
52W High
-26.42%
52W Low
+39.8%
RSI
40.3
Rel Volume
0.27
Avg Volume
135.08K
Volume
35.83K
Perf Week
-1.69%
Perf Month
-7.42%
Perf Quarter
-14.86%
Perf Half Y
-15.78%
-
-
-
-
Beta
0.707
-
-
Volatility
0.14%, 0.39%
Prev Close
0.43%
Price
13.98
Change
-0.14%

ELABS.OL Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.380.340.560.50.65
Net income per share
-0.13-0.14-0.11-0.32-0.36
Operating cash flow per share
-0.08-0.07-0.11-0.12-0.36
Free cash flow per share
-0.19-0.24-0.29-0.35-0.61
Cash per share
0.321.12.211.71.09
Book value per share
0.792.113.493.132.91
Tangible book value per share
0.631.793.112.672.91
Share holders equity per share
0.792.113.493.132.91
Interest debt per share
0.510.290.190.130.18
Market cap
1.55B1.12B2.73B2.29B1.8B
Enterprise value
1.57B1.05B2.53B2.13B1.71B
P/E ratio
-116.96-89.89-243.32-69.47-47.33
Price to sales ratio
40.8537.2249.9844.0326.33
POCF ratio
-192.68-168.38-252.13-179.69-46.91
PFCF ratio
-80.99-51.63-95.97-63.53-27.96
P/B Ratio
19.375.987.967.045.86
PTB ratio
19.375.987.967.045.86
EV to sales
41.2734.7246.3240.8925.01
Enterprise value over EBITDA
-159.56-141.67-705.41-79.58-37.89
EV to operating cash flow
-194.65-157.1-233.68-166.86-44.57
EV to free cash flow
-81.82-48.17-88.95-58.99-26.56
Earnings yield
-0.01-0.010-0.01-0.02
Free cash flow yield
-0.01-0.02-0.01-0.02-0.04
Debt to equity
0.610.120.050.040.03
Debt to assets
0.350.110.050.040.03
Net debt to EBITDA
-1.6210.1855.76.121.99
Current ratio
1.438.9314.6713.137.45
Interest coverage
-4.72-3.72-9.31-34.11-5.35
Income quality
0.470.430.830.321.01
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.140.190.10.110
Research and developement to revenue
000.10.160.17
Intangibles to total assets
0.120.130.10.140
Capex to operating cash flow
1.382.261.631.830.68
Capex to revenue
-0.29-0.5-0.32-0.45-0.38
Capex to depreciation
-2.53-2.78-2.12-2.06-5.61
Stock based compensation to revenue
0.080.130.190.240
Graham number
1.532.582.994.734.85
ROIC
-0.08-0.04-0.03-0.1-0.12
Return on tangible assets
-0.11-0.07-0.03-0.11-0.11
Graham Net
-0.090.942.281.821.19
Working capital
17.17M107.99M246.89M208.44M160.72M
Tangible asset value
63.48M159.86M306.21M278.05M307.11M
Net current asset value
-2.04M90.98M236.36M201.92M142.84M
Invested capital
0.610.120.050.040.03
Average receivables
17.9M19.63M32.47M47.03M58.7M
Average payables
1.68M911.76K2.01M2.35M2.76M
Average inventory
1.56M3.97M3.06M1.55M891K
Days sales outstanding
202.32220.18312.34331.89374.29
Days payables outstanding
6.6710.0621.769.6915.66
Days of inventory on hand
25.0248.99.5110.360
Receivables turnover
1.81.661.171.10.98
Payables turnover
54.6936.2716.7737.6523.31
Inventory turnover
14.597.4638.3735.240
ROE
-0.17-0.07-0.03-0.1-0.12
Capex per share
-0.11-0.17-0.18-0.22-0.25

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.090.040.320.210.09
Net income per share
-0.18-0.140.04-0.07-0.19
Operating cash flow per share
-0.11-0.16-0.12-0.110.02
Free cash flow per share
-0.18-0.22-0.18-0.17-0.04
Cash per share
1.71.471.251.131.09
Book value per share
3.133.023.093.092.91
Tangible book value per share
2.672.542.592.572.91
Share holders equity per share
3.133.023.093.092.91
Interest debt per share
0.080.110.10.280.15
Market cap
2.29B1.57B1.53B1.57B1.8B
Enterprise value
2.13B1.43B1.41B1.48B1.71B
P/E ratio
-30.01-26.3795.56-56.59-22.29
Price to sales ratio
232.79388.0346.0571.7195.17
POCF ratio
-199.12-94.5-127.07-134.5743.58
PFCF ratio
-121.36-69.16-81.88-87.11-399.54
P/B Ratio
7.0454.754.855.86
PTB ratio
7.0454.754.855.86
EV to sales
216.16353.0742.467.56185.44
Enterprise value over EBITDA
-88.81-103.15168.73-302.91-79.24
EV to operating cash flow
-184.9-85.98-117-126.74706.49
EV to free cash flow
-112.69-62.93-75.38-82.09-379.61
Earnings yield
-0.01-0.0100-0.01
Free cash flow yield
-0.01-0.01-0.01-0.010
Debt to equity
0.040.040.030.090.03
Debt to assets
0.040.030.030.080.03
Net debt to EBITDA
6.8310.21-14.5318.544.16
Current ratio
13.1312.4813.6710.657.45
Interest coverage
3.85-28.285.14-5.04-3.75
Income quality
0.50.9-21.35-0.12
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.140.380.080.10
Research and developement to revenue
0.210.720.090.130.31
Intangibles to total assets
0.140.150.150.150
Capex to operating cash flow
0.640.370.550.54-2.86
Capex to revenue
-0.75-1.5-0.2-0.29-0.75
Capex to depreciation
-2.33-1.64-1.77-1.42-4.92
Stock based compensation to revenue
0.30.740.110.080
Graham number
3.63.121.632.153.54
ROIC
-0.04-0.060.01-0.02-0.05
Return on tangible assets
-0.06-0.050.01-0.02-0.06
Graham Net
1.821.621.611.381.19
Working capital
208.44M187.68M194.61M186.67M160.72M
Tangible asset value
278.05M264.3M269.96M268.78M307.11M
Net current asset value
201.92M182.12M190.07M166.97M142.84M
Invested capital
0.040.040.030.090.03
Average receivables
44.21M48.71M63.22M81.43M78.28M
Average payables
1.42M1.35M1.32M2.65M3.77M
Average inventory
891K891K000
Days sales outstanding
432.631.11K207.14355.86684.18
Days payables outstanding
8.864.867.5516.1114.19
Days of inventory on hand
9.470000
Receivables turnover
0.210.080.430.250.13
Payables turnover
10.1518.5111.925.596.34
Inventory turnover
9.50000
ROE
-0.06-0.050.01-0.02-0.07
Capex per share
-0.07-0.06-0.06-0.06-0.07

ELABS.OL Frequently Asked Questions

What is Elliptic Laboratories ASA stock symbol ?

Elliptic Laboratories ASA is a NO stock and trading under the symbol ELABS.OL

What is Elliptic Laboratories ASA stock quote today ?

Elliptic Laboratories ASA stock price is $13.98 today.

Is Elliptic Laboratories ASA stock public?

Yes, Elliptic Laboratories ASA is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Top Correlated Stocks